GSK-3 inhibitor SB 216763, Purity ≥98%

Cat. No.: X24-05-ZQ272

GSK-3 inhibitor SB 216763, Purity ≥98%

Synonym: 280744-09-4; SB-216763; SB216763; GSK-3 inhibitor

  • CAS Number: 280744-09-4
  • Compound CID: 176158
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SB 216763, soluble in DMSO and insoluble in ethanol and water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3α and GSK-3β.
Molecular Weight
371.2
Molecular Formula
C19H12Cl2N2O2
Targets
GSK-3α: 34.3 nM; GSK-3β: 34.3 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 21 mg/mL (56.56 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
SB 216763 is employed to inhibit GSK-3 and study its role in neurodevelopment and cancer.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0